This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

Sustainable Public Pharmaceutical Expenditures Financing Model : Roadmap and Process Management


Continued economic uncertainty and rising healthcare expenditures are making it difficult for many countries to achieve the goal of access to health care services for all segments of their populations within an affordable cost structure. To address these issues, many other countries have initiated cost control mechanisms, focused primarily on pharmaceutical expenditures. A new report from Deloitte Turkey looks specifically how these issues are being addressed in Turkey and offers a possible roadmap for the Turkish government, as well as other countries, to develop a secure and sustainable financing model for public pharmaceutical expenditures.

Stay connected: